Need professional-grade analysis? Visit stockanalysis.com
$45.73B
N/A
2,369
N/A
Price Chart
Risk-Adjusted Performance
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) Price Performance
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) trades on SHE in CNY. The company is classified in the Consumer Defensive sector under the Packaged Foods industry. The stock currently trades at CNY32.87, down 3.32% from the previous close.
Over the past year, 300765 has traded between a low of CNY28.16 and a high of CNY63.00. The stock has lost 28.5% over this period. It is currently 47.8% below its 52-week high.
CSPC Innovation Pharmaceutical Co Ltd Class A has a market capitalization of $45.73B.
About CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Compare CSPC Innovation Pharmaceutical Co Ltd Class A
Side-by-side comparison against top Consumer Defensive peers.
Company Info
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $2.16B
- EBITDA
- $-403,573,024
- Profit Margin
- -11.18%
- EPS (TTM)
- -0.17
- Book Value
- 1.92
Technical Indicators
- 52 Week High
- CN¥63.31
- 52 Week Low
- CN¥27.83
- 50 Day MA
- CN¥32.40
- 200 Day MA
- CN¥40.36
- Beta
- 0.30
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 21.20
- Price/Book
- 17.90
- Enterprise Value
- $46.60B